Analystreport

Mesoblast Limited (NASDAQ: MESO) had its price target lowered by analysts at Cantor Fitzgerald from $23.00 to $17.00.

Mesoblast Limited - American Depositary Shares  (MESO) 
US:NASDAQ Investor Relations: investorsmedia.mesoblast.com